These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10660205)

  • 1. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
    Senan S; van Sörnsen de Koste J; Samson M; Tankink H; Jansen P; Nowak PJ; Krol AD; Schmitz P; Lagerwaard FJ
    Radiother Oncol; 1999 Dec; 53(3):247-55. PubMed ID: 10660205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
    Spoelstra FO; Senan S; Le Péchoux C; Ishikura S; Casas F; Ball D; Price A; De Ruysscher D; van Sörnsen de Koste JR;
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1106-13. PubMed ID: 19560881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
    Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
    Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.
    Giraud P; Elles S; Helfre S; De Rycke Y; Servois V; Carette MF; Alzieu C; Bondiau PY; Dubray B; Touboul E; Housset M; Rosenwald JC; Cosset JM
    Radiother Oncol; 2002 Jan; 62(1):27-36. PubMed ID: 11830310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of gross tumor volume in lung cancer: inter-observer variability.
    Van de Steene J; Linthout N; de Mey J; Vinh-Hung V; Claassens C; Noppen M; Bel A; Storme G
    Radiother Oncol; 2002 Jan; 62(1):37-49. PubMed ID: 11830311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC.
    van Sörnsen de Koste JR; Senan S; Underberg RW; Oei SS; Elshove D; Slotman BJ; Lagerwaard FJ
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):334-9. PubMed ID: 16168828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
    Cui Y; Chen W; Kong FM; Olsen LA; Beatty RE; Maxim PG; Ritter T; Sohn JW; Higgins J; Galvin JM; Xiao Y
    Pract Radiat Oncol; 2015; 5(2):e67-75. PubMed ID: 25413413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of contouring variation with modeled outcome for conformal non-small cell lung cancer radiotherapy.
    Jameson MG; Kumar S; Vinod SK; Metcalfe PE; Holloway LC
    Radiother Oncol; 2014 Sep; 112(3):332-6. PubMed ID: 24853367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
    Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
    Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of lung tumor volumes using three-dimensional computer planning software.
    Bowden P; Fisher R; Mac Manus M; Wirth A; Duchesne G; Millward M; McKenzie A; Andrews J; Ball D
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):566-73. PubMed ID: 12062598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The delineation of target volumes for radiotherapy of lung cancer patients.
    Vorwerk H; Beckmann G; Bremer M; Degen M; Dietl B; Fietkau R; Gsänger T; Hermann RM; Alfred Herrmann MK; Höller U; van Kampen M; Körber W; Maier B; Martin T; Metz M; Richter R; Siekmeyer B; Steder M; Wagner D; Hess CF; Weiss E; Christiansen H
    Radiother Oncol; 2009 Jun; 91(3):455-60. PubMed ID: 19339069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer.
    Sloth Møller D; Knap MM; Nyeng TB; Khalil AA; Holt MI; Kandi M; Hoffmann L
    Acta Oncol; 2017 Nov; 56(11):1604-1609. PubMed ID: 28885090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)?
    Lagerwaard FJ; van de Vaart PJ; Voet PW; Nijssen-Visser MR; Schuchhard-Schipper RH; Joosten HP; Oei SS; Senan S
    Lung Cancer; 2002 Dec; 38(3):297-301. PubMed ID: 12445752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp L; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Hart AA; Nowak PJ; van Herk M; Rasch CR
    Radiother Oncol; 2005 Nov; 77(2):182-90. PubMed ID: 16256231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning.
    Fiorino C; Reni M; Bolognesi A; Cattaneo GM; Calandrino R
    Radiother Oncol; 1998 Jun; 47(3):285-92. PubMed ID: 9681892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
    Greco C; Rosenzweig K; Cascini GL; Tamburrini O
    Lung Cancer; 2007 Aug; 57(2):125-34. PubMed ID: 17478008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.